
HealthBiome races ahead of competitors with approval of postbiotic in Korea and US
South Korean firm HealthBiome Inc’s proprietary postbiotic ingredient has obtained regulatory validation both domestically and by the US FDA, which it says sets itself far ahead of competitors and enables premiumization in both B2B and B2C markets.










































